Cost-effectiveness of dapagliflozin in chronic heart failure: An analysis from the Australian healthcare perspective

Savira, Feby; Wang, B H; Kompa, A R; Ademi, Z; Owen, A J; Zoungas, S; Tonkin, A; Liew, D; Zomer, E

File(s) under permanent embargo

Cost-effectiveness of dapagliflozin in chronic heart failure: An analysis from the Australian healthcare perspective

journal contribution

posted on 2021-09-01, 00:00 authored by Feby SaviraFeby Savira, B H Wang, A R Kompa, Z Ademi, A J Owen, S Zoungas, A Tonkin, D Liew, E Zomer

Cost-effectiveness of dapagliflozin in chronic heart failure: An analysis from the Australian healthcare perspective

History

Journal

European Journal of Preventive Cardiology

Volume

28

Issue

9

Pagination

975 - 982

Publisher

Oxford University Press

Location

Oxford, Eng.

Publisher DOI

https://doi.org/10.1177/2047487320938272

ISSN

2047-4873

eISSN

2047-4881

Language

eng

Author URL

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000606106301054&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a045e4b2bb1f2b747c68c720ec8913b7

Publication classification

C1 Refereed article in a scholarly journal

Usage metrics

Keywords

Cardiac & Cardiovascular Systems Cardiovascular System & Cardiology cost-effectiveness Dapagliflozin heart failure hospitalisation incremental cost-effectiveness ratio Life Sciences & Biomedicine Science & Technology TYPE-2 DIABETES-MELLITUS

Licence

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

File(s) under permanent embargo

Cost-effectiveness of dapagliflozin in chronic heart failure: An analysis from the Australian healthcare perspective

History

Journal

Volume

Issue

Pagination

Publisher

Location

Publisher DOI

ISSN

eISSN

Language

Author URL

Publication classification

Usage metrics

Categories

Keywords

Licence

Exports